Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)


Adrián LLerena, MD, Ph.D
Extremadura University
Hospital and Medical School
Badajoz, Extremadura


Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:14   Issue:2
Pp: 65-65
Ari Hirvonen*
DOI: 10.2174/187569211402170424204837

Editorial: CPPM Onward and Upward: Global Personalized Medicine Guided by Responsible Innovation free to download

Volume:14   Issue:2
Pp: 66-67
Adrian Llerena* and Vural Ozdemir
DOI: 10.2174/187569211402170424205258

DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy

Volume:14   Issue:2
Pp: 68-73
Karimpanakkal C. Ajithkumar and Kannissery Pramod*
DOI: 10.2174/1875692115666170208121925

Impact of New Technologies on Pharmacogenomics

Volume:14   Issue:2
Pp: 74-85
Maria Isidoro-Garcia*, Almudena Sanchez-Martin and Belen Garcia-Berrocal
DOI: 10.2174/1875692115666170214152152

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

Volume:14   Issue:2
Pp: 86-105
Germana Castelli, Elvira Pelosi and Ugo Testa*
DOI: 10.2174/1875692115666170224094023

Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs

Volume:14   Issue:2
Pp: 106-123
Upinder Kaur, Sankha S. Chakrabarti and Indrajeet S. Gambhir*
DOI: 10.2174/1875692115666170403101207

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

Volume:14   Issue:2
Pp: 124-133
Assaad Y. Semaan, Kristin R. Delfino, Andrew C. Wilber, Thomas K. Mathews, Kathy J. Robinson, Laurent Brard and Shaheen R. Alanee*
DOI: 10.2174/1875692115666170126152349


Volume:14   Issue:2
Pp: 134-134

DOI: 10.2174/187569211402170424211446